<DOC>
	<DOCNO>NCT00683410</DOCNO>
	<brief_summary>To collect post-marketing information safety Prevenar Filipino patient</brief_summary>
	<brief_title>Post-Marketing Study Safety Prevenar ( Pneumococcal Conjugate Vaccine , 7-valent )</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>All patient study center receive receive least one dose Prevenar accord approve product indication . Previously discontinue Prevenar therapy due safety concern .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>